CS logo
small CS logo
Hollings Cancer Center at Medical University of South Carolina

Charleston, South Carolina, United States
Urologist in Charleston, South Carolina
86 Jonathan Lucas St 1st Floor, Charleston, SC 29425

About Hollings Cancer Center at Medical University of South Carolina


"MUSC Health is no longer seeing patients at this facility."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
SWOG Cancer Research Network
44
Children's Oncology Group
42
Radiation Therapy Oncology Group
21
Medical University of South Carolina
17
Pfizer
11
Alliance for Clinical Trials in Oncology
10
Seagen Inc.
9
Hoffmann-La Roche
8
Novartis Pharmaceuticals
8
Bristol-Myers Squibb
6
NSABP Foundation Inc
6
Total Rows: 100

Clinical Trials at Hollings Cancer Center at Medical University of South Carolina


During the past decade, Hollings Cancer Center at Medical University of South Carolina conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 100 clinical trials were completed, i.e. on average, 151.5% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 29 clinical trials were completed. i.e. 193.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years77151599101010105555441166111123232222999911116633Started TrialsCompleted Trails2015201620172018201920202021202220230102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
1996-06-01
2012-03-01
Completed
221
SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial
1997-02-01
Completed
180
S9630, Medroxyprogesterone in Treating Women With Breast Cancer
1997-03-01
2009-12-01
Completed
313
Combination Chemotherapy in Treating Children With Progressive Brain Tumors
1997-04-01
2012-04-01
Completed
428
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
1997-08-01
2011-01-01
Completed
483
Combination Chemotherapy in Treating Children With Neuroblastoma
1988-03-01
2011-01-01
Completed
573
Surgery in Treating Children With Neuroblastoma
1998-03-01
2006-03-01
Completed
968
Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva
1999-12-01
Completed
515

Rows per page:

1–100 of 301

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hollings Cancer Center at Medical University of South Carolina" #1 sponsor was "SWOG Cancer Research Network" with 44 trials, followed by "Children's Oncology Group" with 42 trials sponsored, "Radiation Therapy Oncology Group" with 21 trials sponsored, "Medical University of South Carolina" with 17 trials sponsored and "Pfizer" with 17 trials sponsored. Other sponsors include 161 different institutions and companies that sponsored additional 102 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hollings Cancer Center at Medical University of South Carolina" #1 collaborator was "National Cancer Institute (NCI)" with 143 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "Merck Sharp & Dohme LLC" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 74 different institutions and companies that were collaborators in the rest 61 trials.
Created with Highcharts 11.1.0Top Leading SponsorsSWOG Cancer ResearchNetwork: 44SWOG Cancer ResearchNetwork: 44Children's Oncology Group: 42Children's Oncology Group: 42Radiation TherapyOncology Group: 21Radiation TherapyOncology Group: 21Medical University ofSouth Carolina: 17Medical University ofSouth Carolina: 17Pfizer: 11Pfizer: 11Alliance for ClinicalTrials in Oncology: 10Alliance for ClinicalTrials in Oncology: 10Seagen Inc.: 9Seagen Inc.: 9Hoffmann-La Roche: 8Hoffmann-La Roche: 8Novartis Pharmaceuticals: 8Novartis Pharmaceuticals: 8Bristol-Myers Squibb: 6Bristol-Myers Squibb: 6

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 143National CancerInstitute (NCI): 143NRG Oncology: 13NRG Oncology: 13Cancer and LeukemiaGroup B: 10Cancer and LeukemiaGroup B: 10Merck Sharp & Dohme LLC: 8Merck Sharp & Dohme LLC: 8SWOG Cancer ResearchNetwork: 6SWOG Cancer ResearchNetwork: 6Eastern CooperativeOncology Group: 4Eastern CooperativeOncology Group: 4North Central CancerTreatment Group: 4North Central CancerTreatment Group: 4Novartis Pharmaceuticals: 4Novartis Pharmaceuticals: 4Bayer: 3Bayer: 3Hoosier CancerResearch Network: 3Hoosier CancerResearch Network: 3

Clinical Trials Conditions at Hollings Cancer Center at Medical University of South Carolina


According to Clinical.Site data, the most researched conditions in "Hollings Cancer Center at Medical University of South Carolina" are "Leukemia" (30 trials), "Lung Cancer" (22 trials), "Breast Cancer" (21 trials), "Prostate Cancer" (20 trials) and "Head and Neck Cancer" (14 trials). Many other conditions were trialed in "Hollings Cancer Center at Medical University of South Carolina" in a lesser frequency.

Clinical Trials Intervention Types at Hollings Cancer Center at Medical University of South Carolina


Most popular intervention types in "Hollings Cancer Center at Medical University of South Carolina" are "Drug" (258 trials), "Radiation" (62 trials), "Biological" (56 trials), "Procedure" (42 trials) and "Other" (30 trials). Other intervention types were less common.
The name of intervention was led by "radiation therapy" (36 trials), "Placebo" (27 trials), "cyclophosphamide" (25 trials), "etoposide" (21 trials) and "filgrastim" (21 trials). Other intervention names were less common.

Clinical Trials Genders at Hollings Cancer Center at Medical University of South Carolina


The vast majority of trials in "Hollings Cancer Center at Medical University of South Carolina" are 261 trials for "All" genders, 20 trials for "Female" genders and 20 trials for "Male" genders.

Clinical Trials Status at Hollings Cancer Center at Medical University of South Carolina


Currently, there are NaN active trials in "Hollings Cancer Center at Medical University of South Carolina". undefined are not yet recruiting, 15 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 199 completed trials in Hollings Cancer Center at Medical University of South Carolina, undefined suspended trials, and 47 terminated clinical trials to date.
Out of the total trials that were conducted in Hollings Cancer Center at Medical University of South Carolina, 41 "Phase 1" clinical trials were conducted, 139 "Phase 2" clinical trials and 110 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 139Phase 2: 139Phase 3: 110Phase 3: 110Phase 1: 41Phase 1: 41Not Applicable: 11Not Applicable: 11Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 199Completed: 199Terminated: 47Terminated: 47Active, not recruiting: 27Active, not recruiting: 27Recruiting: 15Recruiting: 15Unknown status: 10Unknown status: 10No longer available: 2No longer available: 2Withdrawn: 1Withdrawn: 1